Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (7): 616-621    DOI: 10.19485/j.cnki.issn2096-5087.2024.07.015
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
房山区居民糖尿病患病率、知晓率、治疗率和控制率分析
龚海英, 邢瑞婷, 刘晓芬, 苗雨阳, 郑可昕, 赵耀
北京市房山区疾病预防控制中心慢病科,北京 102488
The prevalence, awareness, treatment and control rates of diabetes among residents in Fangshan District
GONG Haiying, XING Ruiting, LIU Xiaofen, MIAO Yuyang, ZHENG Kexin, ZHAO Yao
Department of Chronic Diseases, Fangshan District Center for Disease Control and Prevention, Beijing 102488, China
全文: PDF(847 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解北京市房山区居民糖尿病患病率、知晓率、治疗率和控制率,为加强糖尿病防控提供参考。方法 采用多阶段分层整群抽样方法,于2023年3—6月抽取房山区18~79岁常住居民为调查对象,通过问卷调查、体格检查和实验室检测收集人口学信息、生活方式、体质指数、空腹血糖和血脂等资料,分析糖尿病患病率、知晓率、治疗率和控制率,并采用多因素logistic回归模型分析其影响因素。结果 调查4 438人,其中男性2 367人,占53.33%;女性2 071人,占46.67%。年龄为(44.99±14.90)岁。糖尿病患病率、知晓率、治疗率和控制率分别为15.75%、57.37%、56.22%和22.90%。多因素logistic回归分析结果显示,年龄(30~<40岁,OR=1.624,95%CI:1.011~2.609;40~<50岁,OR=3.469,95%CI:2.163~5.561;50~<60岁,OR=4.202,95%CI:2.595~6.803;60~<70岁,OR=7.229,95%CI:4.406~11.862;70~79岁,OR=7.929,95%CI:4.665~13.479)、肥胖(OR=1.368,95%CI:1.071~1.748)、高血压(OR=1.943,95%CI:1.601~2.359)和血脂异常(OR=2.754,95%CI:2.287~3.317)是糖尿病患病的影响因素;性别(女,OR=1.529,95%CI:1.019~2.293)、年龄(40~<50岁,OR=4.971,95%CI:1.681~14.698;50~<60岁,OR=6.070,95%CI:2.045~18.020;60~<70岁,OR=6.902,95%CI:2.287~20.832;70~79岁,OR=6.954,95%CI:2.191~22.070)和高血压(OR=1.906,95%CI:1.337~2.718)是糖尿病知晓的影响因素;年龄(40~<50岁,OR=4.699,95%CI:1.594~13.855;50~<60岁,OR=5.990,95%CI:2.023~17.732;60~<70岁,OR=7.134,95%CI:2.370~21.470;70~79岁,OR=6.639,95%CI:2.102~20.964)和高血压(OR=1.857,95%CI:1.304~2.645)是糖尿病治疗的影响因素;年龄(40~<50岁,OR=2.948,95%CI:1.349~6.438;60~<70岁,OR=2.344,95%CI:1.049~5.234)是糖尿病控制的影响因素。结论 房山区居民糖尿病患病率较高,知晓率、治疗率和控制率改善不明显,对高龄、肥胖、高血压和血脂异常居民应加强糖尿病健康教育和管理。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
龚海英
邢瑞婷
刘晓芬
苗雨阳
郑可昕
赵耀
关键词 糖尿病患病率知晓率治疗率控制率影响因素    
AbstractObjective To investigate the prevalence, awareness, treatment and control rates of diabetes among residents in Fangshan District, Bejing Municipality, so as to provide reference for strengthening the prevention and control of diabetes. Methods The residents aged 18 to 79 years were selected in Fangshan District using multistage stratified cluster sampling method from March to June 2023. Demographic information, lifestyle, body mass index, fasting blood glucose, and blood lipid were collected through questionnaire surveys, physical examinations and laboratory tests. The prevalence, awareness, treatment and control rates of diabetes among residents were analyzed and their influencing factors were identified using a multivariable logistic regression model. Results A total of 4 438 residents were enrolled, including 2 367 males (53.33%) and 2 071 females (46.67%), and had a mean age of (44.99±14.90) years. The prevalence, awareness, treatment and control rates of diabetes were 15.75%, 57.37%, 56.22% and 22.90%, respectively. Multivariable logistic regression analysis showed that age (aged 30 to 39 years, OR=1.624, 95%CI: 1.011-2.609; aged 40 to 49 years, OR=3.469, 95%CI: 2.163-5.561; aged 50 to 59 years, OR=4.202, 95%CI: 2.595-6.803; aged 60 to 69 years, OR=7.229, 95%CI: 4.406-11.862; aged 70 to 79 years, OR=7.929, 95%CI: 4.665-13.479), obesity (OR=1.368, 95%CI: 1.071-1.748), hypertension (OR=1.943, 95%CI: 1.601-2.359) and dyslipidemia (OR=2.754, 95%CI: 2.287-3.317) were the factors affecting the prevalence of diabetes. Sex (women, OR=1.529, 95%CI: 1.019-2.293), age (aged 40 to 49 years, OR=4.971, 95%CI: 1.681-14.698; aged 50 to 59 years, OR=6.070, 95%CI: 2.045-18.020; aged 60 to 69 years, OR=6.902, 95%CI: 2.287-20.832; aged 70 to 79 years, OR=6.954, 95%CI: 2.191-22.070) and hypertension (OR=1.906, 95%CI: 1.337-2.718) were the factors affecting the awareness of diabetes. Age (aged 40 to 49 years, OR=4.699, 95%CI: 1.594-13.855; aged 50 to 59 years, OR=5.990, 95%CI: 2.023-17.732; aged 60 to 69 years, OR=7.134, 95%CI: 2.370-21.470; aged 70 to 79 years, OR=6.639, 95%CI: 2.102-20.964) and hypertension (OR=1.857, 95%CI: 1.304-2.645) were the factors affecting the treatment of diabetes. Age (aged 40 to 49 years, OR=2.948, 95%CI: 1.349-6.438; aged 60 to 69 years, OR=2.344, 95%CI: 1.049-5.234) was the factor affecting the control of diabetes. Conclusions The prevalence rate of diabetes among residents in Fangshan District was high, and the improvements of awareness rate, treatment rate and control rate were not obvious. Health education and management of diabetes should be strengthened for elderly, hypertensive and dyslipidemic residents.
Key wordsdiabetes    prevalence rate    awareness rate    treatment rate    control rate    influencing factor
收稿日期: 2024-04-02      修回日期: 2024-06-18      出版日期: 2024-07-10
中图分类号:  R587  
作者简介: 龚海英,博士,副主任医师,主要从事慢性病防制工作
通信作者: 赵耀,E-mail:yue1112@163.com   
引用本文:   
龚海英, 邢瑞婷, 刘晓芬, 苗雨阳, 郑可昕, 赵耀. 房山区居民糖尿病患病率、知晓率、治疗率和控制率分析[J]. 预防医学, 2024, 36(7): 616-621.
GONG Haiying, XING Ruiting, LIU Xiaofen, MIAO Yuyang, ZHENG Kexin, ZHAO Yao. The prevalence, awareness, treatment and control rates of diabetes among residents in Fangshan District. Preventive Medicine, 2024, 36(7): 616-621.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.07.015      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I7/616
[1] CHO N H,SHAW J E,KARURANGA S,et al.IDF Diabetes Atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018,138:271-281.
[2] SAEEDI P,PETERSOHN I,SALPEA P,et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045:results from the International Diabetes Federation Diabetes Atlas,9th edition[J/OL].Diabetes Res Clin Pract,2019,157[2024-06-18].https://doi.org/10.1016/j.diabres.2019.107843.
[3] XU Y,WANG L M,HE J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.
[4] LI Y Z,TENG D,SHI X G,et al.Prevalence of diabetes recorded in mainland China using2018 diagnostic criteria from the American Diabetes Association:national cross sectional study[J/OL].BMJ,2020,369[2024-06-18].https://doi.org/10.1136/bmj.m997.
[5] 林深荣. 社会经济地位与高血压、糖尿病关系的队列研究[D].贵阳:贵州大学,2023.
[6] 何莹,赵清水,张丽娜.2010—2016年北京市房山区慢性病死亡及四类慢病早死概率研究[J].首都公共卫生2018,12(6):307-309.
[7] 刘晓芬,何莹,魏柯雯,等.北京市房山区成人常见慢性病流行特征及控制现状调查[J].中国慢性病预防与控制,2019,27(8):605-607.
[8] 于宁,张梅,张笑,等.中国中老年居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J].中华流行病学杂志,2023,44(2):196-204.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[10] 中国高血压防治指南修订委员会,中国高血压联盟,中华医学会心血管病学分会中国医师协会高血压专业委员会,等.中国高血压防治指(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[11] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
[12] 中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004,26(1):1-4.
[13] 曹亚景,唐丽娟,赵晶晶,等.河北省成年居民血脂异常与糖尿病家族史对糖尿病患病的交互作用[J].中华糖尿病杂志,2023,15(1):39-46.
[14] 高艳青,巩俐彤,梁国欣.北京市大兴区居民糖尿病患病率及其影响因素分析[J].中国临床医生杂志,2022,50(11):1322-1325.
[15] YAN Y Q,WU T T,ZHANG M,et al.Prevalence,awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population[J].BMC Public Health,2022,22(1):1-6.
[16] 苏健,崔岚,杜文聪,等.江苏省居民高血压患病率、知晓率、治疗率和控制率分析[J].中华流行病学杂志,2019,40(9):1139-1144.
[17] 李卉,戚敏杰,张寒雪,等.河南省60岁及以上老年人糖尿病患病、知晓、治疗和控制率的流行现状[J].中国健康教育,2022,38(12):1066-1071.
[18] 阮元,李娟娟,董海燕,等.云南省特有少数民族2型糖尿病患病和控制状况分析[J].中国慢性病预防与控制,2023,31(11):852-855.
[19] 董亚苒,张润华,佘其美,等.北京市石景山社区40岁及以上居民糖尿病知晓率、治疗率和控制率调查[J].中国临床保健杂志,2022,25(3):322-327.
[20] SUN Y Y,NI W Q,YUAN X L,et al.Prevalence,treatment,control of type 2 diabetes and the risk factors among elderly people in Shenzhen:results from the urban Chinese population[J].BMC Public Health,2020,20(1):2-3.
[21] 丁承辉,吴萃,薛琨,等.宝山区糖尿病高危人群筛查结果分析[J].预防医学,2024,35(6):512-513.
[22] 于晓晨,刘云飞,王丽,等.辽宁省≥40岁城市居民糖尿病知晓率、治疗率和控制率现状及影响因素分析[J].现代预防医学,2022,49(15):2845-2850.
[23] 王慧,高霞,朱晓云,等.社区2型糖尿病患者血糖控制达标的影响因素分析[J].预防医学,2024,36(5):426-427.
[1] 梁薇, 任梦婷, 张文科, 杨琳, 王红雨. 滁州市中小学生脊柱侧弯筛查结果[J]. 预防医学, 2024, 36(7): 607-610.
[2] 王凝雨, 张忠敏, 陈婷. 青少年抑郁症状的影响因素研究[J]. 预防医学, 2024, 36(7): 562-566,570.
[3] 曹明鑫, 杨濮瑞, 郭爱敏. 慢性阻塞性肺疾病吸烟患者尼古丁依赖的影响因素分析[J]. 预防医学, 2024, 36(7): 575-579.
[4] 陈德彬, 申锦玉. 厦门市居民慢性病患病情况调查[J]. 预防医学, 2024, 36(7): 622-625.
[5] 尉芝苗, 韩明明, 钱雯, 魏咏兰, 王亮. 成都市居民血脂异常的影响因素研究[J]. 预防医学, 2024, 36(7): 598-602.
[6] 程远芬, 彭佳, 李丹, 杨娟华, 杨婷, 曹煜. 社区医务人员职业延迟满足情况调查[J]. 预防医学, 2024, 36(7): 603-606.
[7] 郭震, 朱斌斌, 何晓庆, 陈强. 医药化工企业职工颈肩部职业性肌肉骨骼疾患调查[J]. 预防医学, 2024, 36(6): 527-531.
[8] 张思雨, 夏木斯叶·木依都力, 张俊, 阿迪拉·苏力旦, 王雯雷, 依力夏提·库来西, 夏依达·乌斯满江, 张仕杰, 张荣. 新疆维吾尔自治区成人高尿酸血症的影响因素分析[J]. 预防医学, 2024, 36(6): 540-542,547.
[9] 贾晓锋, 王慧群, 石敏, 汤婕, 任静霞. HIV/AIDS病例HIV相关神经认知障碍的影响因素分析[J]. 预防医学, 2024, 36(6): 461-464.
[10] 吴丹红, 王伟霞, 王良友, 乔冬菊, 黄依璐, 张嫣. 台州市4类慢性病死亡及早死概率分析[J]. 预防医学, 2024, 36(5): 428-431,436.
[11] 王慧, 高霞, 朱晓云, 马芳军. 社区2型糖尿病患者血糖控制达标的影响因素分析[J]. 预防医学, 2024, 36(5): 423-427.
[12] 李庆伟, 陈雪梅, 王霄凯, 丁佳妮, 于方圆, 陈亦芳. 金山区孕妇被动吸烟调查[J]. 预防医学, 2024, 36(5): 457-460.
[13] 喜小梅, 吕雅莉, 刘永斌, 祁生顺, 吴建军, 魏兴民. 石化企业职工代谢综合征调查[J]. 预防医学, 2024, 36(5): 432-436.
[14] 蔡锋成, 徐萌艳, 吴映瑛, 刘蓓, 祝莉. 孕妇睡眠障碍的影响因素研究[J]. 预防医学, 2024, 36(5): 440-443.
[15] 陈琦, 薛霏, 桂娟娟, 吕鑫, 谢锋. MSM人群HIV/AIDS病例的结婚意愿调查[J]. 预防医学, 2024, 36(5): 397-401.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed